To further evaluate alterations in intracellular signaling after modulating uPAR expression, we evaluated AKT, which was suggested to be frequently activated in MM cells (Supplementary Figure S2A, S2B) and downstream proteins, pS6K and S6, which are important components of the mTOR pathways [21]. The gene discussed is MTOR; the disease is Miyoshi myopathy.